Weight Loss Drugs As US Prescriptions Skyrocket

Novo Nordisk A/S Ozempic brand semaglutide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. Prescriptions of appetite suppressing GLP-1 weight-loss drugs skyrocketed 300% from 2020 to 2022. Photographer: George Frey/Bloomberg via Getty Images

Weight Loss Drugs As US Prescriptions Skyrocket
Novo Nordisk A/S Ozempic brand semaglutide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. Prescriptions of appetite suppressing GLP-1 weight-loss drugs skyrocketed 300% from 2020 to 2022. Photographer: George Frey/Bloomberg via Getty Images
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesWeight Loss Drugs As US Prescriptions Skyrocket, News PhotoWeight Loss Drugs As US Prescriptions Skyrocket, News PhotoWeight Loss Drugs As US Prescriptions Skyrocket Get premium, high resolution news photos at Getty ImagesProduct #:1807240703
$499$175
Getty Images
In stock

DETAILS

Credit: Bloomberg / Contributor

Getty Images editorial coverage is captured by expert trusted visual journalists. Learn more about our editorial policies.

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Editorial #:
1807240703
Collection:
Bloomberg
Date created:
November 27, 2023
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
WEIGHT LOSS DRUGS
Max file size:
7295 x 4863 px (24.32 x 16.21 in) - 300 dpi - 18 MB